Mimedx (MDXG) EBIT Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,578.00 |
| Dec 31, 2025 | 4,132.00 |
| Sep 30, 2025 | 3,461.00 |
| Jun 30, 2025 | 2,346.00 |
| Mar 31, 2025 | 3,162.00 |
| Dec 31, 2024 | 1,827.00 |
| Sep 30, 2024 | -270.00 |
| Jun 30, 2024 | 5,221.00 |
| Mar 31, 2024 | 3,573.00 |
| Dec 31, 2023 | 2,750.00 |
| Sep 30, 2023 | 1,318.00 |
| Jun 30, 2023 | 1,158.00 |
| Mar 31, 2023 | -400.00 |
| Dec 31, 2022 | -1,209.00 |
| Sep 30, 2022 | -2,102.00 |
| Jun 30, 2022 | -2,337.00 |
| Mar 31, 2022 | -2,478.00 |
| Dec 31, 2021 | 1,519.00 |
| Sep 30, 2021 | -900.00 |
| Jun 30, 2021 | -681.00 |
| Mar 31, 2021 | -1,418.00 |
| Dec 31, 2020 | -3,843.00 |
| Sep 30, 2020 | -2,879.00 |
| Jun 30, 2020 | -2,329.00 |
| Mar 31, 2020 | -3,268.00 |
| Dec 31, 2019 | -1,813.00 |
| Sep 30, 2019 | 485.00 |
| Jun 30, 2019 | -2,378.00 |
| Mar 31, 2019 | -1,560.00 |
| Dec 31, 2018 | -181.00 |
| Sep 30, 2018 | 202.00 |
| Jun 30, 2018 | 726.00 |
| Mar 31, 2018 | 549.00 |
| Dec 31, 2017 | 3,655.00 |
| Sep 30, 2017 | 5,622.00 |
| Jun 30, 2017 | 1,137.00 |
| Mar 31, 2017 | 2,603.00 |
| Dec 31, 2016 | 7,977.00 |
| Sep 30, 2016 | 8,408.00 |
| Jun 30, 2016 | 13,145.00 |
| Mar 31, 2016 | 31,481.00 |